Publikationen 2021

  • Arakelyan A, Kempkensteffen J, Verthein U (2021) Systematische Literaturübersicht der Wirksamkeit von Acamprosat, Naltrexon, Disulfiram und Nalmefen zur Trinkmengenreduktion und Aufrechterhaltung der Abstinenz bei Alkoholabhängigkeit. Suchttherapie, eFirst. DOI: 10.1055/a-1494-4333
  • Frischknecht U, Hoffmann S, Steinhauser A, Lindemann L, Buchholz A, Manthey J, Schulte B, Rehm J, Kraus L, Verthein U, Reimer J, Kiefer F (2021) Diagnostik und Behandlung alkoholbezogener Störungen – Versorgerbefragung zur Erarbeitung von Strategien der Leitlinienimplementierung. Suchttherapie; 22: 141 - 151. DOI 10.1055/a-1265-4687
  • Zurhold H, Martens M, Degkwitz P, Rosenkranz M, Verthein U (2021) Analyse biografischer Ereignisse bei unterschiedlichen Gruppen von Konsumierenden amphetaminartiger Substanzen in Deutschland: Eine qualitative Studie. Suchttherapie; 22: 132-140. DOI: 10.1055/a-1334-2833
  • Kalke J, Manthey J, Rosenkranz M, Rehm J & Verthein U (2021) Wie sollte ein Modellversuch zur kontrollierten Abgabe von Cannabis aus Sicht der Konsument*innen ausgestaltet sein? Ergebnisse einer Befragung aus Berlin. In: akzept e. V. Bundesverband, Hrsg. 8. Alternativer Drogen- und Suchtbericht. Lengerich: Pabst Science Publishers 163-171
  • Manthey J, Solovei A, Anderson P, Carr S, Rehm J (2021) Can alcohol consumption in Germany be reduced by alcohol screening, brief intervention and referral to treatment in primary health care? Results of a simulation study. PLoS One, 5;16(8):e0255843. doi: 10.1371/journal.pone.0255843 
  • López-Pelayo H, Campeny E, Oliveras C, Rehm J, Manthey J, Gual A, Balcells-Olivero MLM (2021) Early, Chronic, and Acute Cannabis Exposure and Their Relationship With Cognitive and Behavioral Harms. Front Psychiatry, 9;12:643556. doi: 10.3389/fpsyt.2021.643556 
  • Tran A, Manthey J, Lange S, Jiang H, Štelem?kas M, Liutkut?-Gumarov V, Meš?eriakova-Veliulien? O, Petkevi?ien? J, Radišauskas R, Telksnys T, Rehm J (2021) Alcohol control policies add to secular trends in all-cause mortality rates in young adults. Sci Rep, 23;11(1):15127. doi: 10.1038/s41598-021-94562-1
  • O'Donnell A, Schulte B, Manthey J, Schmidt CS, Piazza M, Chavez IB, Natera G, Aguilar NB, Hernández GYS, Mejía-Trujillo J, Pérez-Gómez A, Gual A, de Vries H, Solovei A, Kokole D, Kaner E, Kilian C, Rehm J, Anderson P, Jané-Llopis E (2021) Primary care-based screening and management of depression amongst heavy drinking patients: Interim secondary outcomes of a three-country quasi-experimental study in Latin America. PLoS One, 5;16. doi: 10.1371/journal.pone.0255594
  • Lopez-Pelayo H, Matrai S, Balcells-Olivero M, Campeny E, Braddick F, Bossong M, Cruz OS, Deluca P, Dom G, Feingold D, Freeman TP, Guzman P, Hindocha BC, Kelly N, Liebregts N, Lorenzetti V, Manthey J, Matias J, Oliveras C, Pons MT, Rehm J, Rosenkranz M, Swithenbank Z, van Deurse L, Vicente J, Vuolo M, Wojnar M, Gual A (2021) Standard units for cannabis dose: Why is it important to standardize cannabis dose for drug policy and how can we enhance its place on the public health agenda? International Journal of Drug Policy, 97, 103350
  • Kilian C, Rehm J, Allebeck P, Braddick F, Gual A, Barták M, Bloomfield K, Gil A, Neufeld M, O'Donnell A, Petruželka B, Rogalewicz V, Schulte B, Manthey J, the European Study Group on Alcohol Use and COVID-19 (2021) Alcohol consumption during the COVID-19 pandemic in Europe: a large-scale cross-sectional study in 21 countries. Addiction, https://doi.org/10.1111/add.15530
  • López-Pelayo H, Matrai S, Balcells-Olivero M, Campeny E, Braddick F, Bossong MG, Cruz OS, Deluca P, Dom G, Feingold D, Freeman TP, Guzman P, Hindocha C, Kelly BC, Liebregts N, Lorenzetti V, Manthey J, Matias J, Oliveras C, Pons MT, Rehm J, Rosenkranz M, Swithenbank Z, van Deurse L, Vicente J, Vuolo M, Wojnar M and Gual A (2021) Supporting Future Cannabis Policy – Developing a Standard Joint Unit: A Brief Back-Casting Exercise. Frontiers in Psychiatry; 12(606)
  • Kilian C, Rehm J, Allebeck P, Barták M, Braddick F, Gual A, Matrai S, Petruželka B, Rogalewicz V, Rossow I, Schulte B, Štelemekas M, Manthey J (2021) Conducting a multi-country online alcohol survey in the time of the COVID-19 pandemic: Opportunities and challenges. Int J Methods Psychiatr Res. doi: 10.1002/mpr.1875
  • Bruguera P, Barrio P, Manthey J, Oliveras C, López-Pelayo H, Nuño L, Miquel L, López-Lazcano A, Blithikioti C, Caballeria E, Matrai S, Rehm J, Vieta E, Gual A (2021) Mid and long-term effects of a SBIRT program for at-risk drinkers attending to an emergency department. Follow-up results from a randomized controlled trial. Eur J Emerg Med. doi: 10.1097/MEJ.0000000000000810
  • Chrystoja BR, Rehm J, Manthey J, Probst C, Wettlaufer A, Shield KD (2021). A systematic comparison of the global comparative risk assessments for alcohol. Addiction. doi: 10.1111/add.15413
  • Llamosas-Falcón L, Shield KD, Gelovany M, Hasan OSM, Manthey J, Monteiro M, Walsh N, Rehm J (2021) Impact of alcohol on the progression of HCV-related liver disease: A systematic review and meta-analysis. J Hepatol. 20, doi: 10.1016/j.jhep.2021.04.018
  • Rehm J, Štelemekas M, Ferreira-Borges C, Jiang H, Lange S, Neufeld M, Room R, Casswell S, Tran A, Manthey J (2021) Classifying Alcohol Control Policies with Respect to Expected Changes in Consumption and Alcohol-Attributable Harm: The Example of Lithuania, 2000-2019. Int J Environ Res Public Health. 2;18(5):2419. doi: 10.3390/ijerph18052419
  • Barrio P, Baldaquí N, Andreu M, Kilian C, Rehm J, Gual A, Manthey J (2021) Abstinence Among Alcohol Use Disorder Patients During the COVID-19 Pandemic: Insights From Spain. Alcohol Clin Exp Res.45:802-807. doi: 10.1111/acer.14555
  • Stelemekas M, Manthey J, Badaras R, Casswell S, Ferreira-Borges C, Kalediene R, Lange S, Neufeld M, Petkeviciene J, Radišauskas R, Room R, Telksnys T, Zurlyte I, Rehm J (2021) Alcohol control policy measures and all-cause mortality in Lithuania: an interrupted time-series analysis. Addiction. 2021 doi: 10.1111/add.15470
  • Anderson P, O'Donnell A, Kaner E, Llopis EJ, Manthey J, Rehm J (2021) Impact of minimum unit pricing on alcohol purchases in Scotland and Wales: controlled interrupted time series analyses. Lancet Public Health. doi: 10.1016/S2468-2667(21)00052-9
  • Manthey J, Kilian C, Carr S, Allebeck P, Braddick F, Gual A, Barták M, Bloomfield K, Gil A, Neufeld M, O’Donnell A, Petruželka B, Rogalewicz V, Schulte B, Rehm J (2021) Use of alcohol, tobacco, cannabis, and other substances during the first wave of the SARS-CoV-2 pandemic in Europe: a survey on 36,000 European substance users. Subst Abuse Treat Prev Policy 16, 36. https://doi.org/10.1186/s13011-021-00373-y
  • Kokole D, Jané-Llopis E, Mercken L, Piazza M, Bustamante I, Natera Rey G, Medina P, Pérez-Gómez A, Mejía-Trujillo J, O'Donnell A, Kaner E, Gual A, Schmidt CS, Schulte B, Candel MJJM, de Vries H, Anderson P (2021) Factors associated with primary health care providers' alcohol screening behavior in Colombia, Mexico and Peru. Subst Abus; 13:1-9. doi: 10.1080/08897077.2021.1903658
  • Kilian C, Manthey J, Carr S, Hanschmidt F, Rehm J, Speerforck S, Schomerus S (2021). Stigmatisation of people with alcohol use disorders: an updated systematic review of population studies. Alcoholism: Clinical and Experimental Research. doi: 10.1111/acer.14598
  • Manthey J, Hassan SA, Carr S, Kilian C, Kuitunen-Paul S, Rehm J (2021) What are the economic costs to society attributable to alcohol use? A systematic review and modelling study. PharmacoEconomics. doi: 10.1007/s40273-021-01031-8
  • Manthey J, Hassan SA, Carr S, Kilian C, Kuitunen-Paul S, Rehm J (2021) Estimating the economic consequences of substance use and substance use disorders. Expert Review of Pharmacoeconomics & Outcomes Research. doi: 10.1080/14737167.2021.1916470
  • Bruguera P, Barrio P, Manthey J, Oliveras C, López-Pelayo H, Nuño L, Miquel L, López-Lazcano A, Blithikioti C, Caballeria E, Matrai S, Rehm J, Vieta E, Gual A (2021) Mid and long-term effects of a SBIRT program for at-risk drinkers attending to an emergency department. Follow-up results from a randomized controlled trial. Eur J Emerg Med. doi: 10.1097/MEJ.0000000000000810
  • Llamosas-Falcón L, Shield KD, Gelovany M, Hasan OSM, Manthey J, Monteiro M, Walsh N, Rehm J (2021) Impact of alcohol on the progression of HCV-related liver disease: A systematic review and meta-analysis. J Hepatol. doi: 10.1016/j.jhep.2021.04.018
  • Chrystoja BR, Rehm J, Manthey J, Probst C, Wettlaufer A, Shield KD (2021) A systematic comparison of the global comparative risk assessments for alcohol. Addiction doi: 10.1111/add.15413
  • Moazen-Zadeh E, Ziafat K, Yazdani K, Kamel MM, Wong JSH, Modabbernia A, Blanken P, Verthein U, Schütz CG, Jang K, Akhondzadeh S, Krausz RM (2021) Impact of opioid agonist treatment on mental health in patients with opioid use disorder: a systematic review and network meta-analysis of randomized clinical trials. Am J Drug Alcohol Abuse; 29:1-25. doi: 10.1080/00952990.2021.1887202
  • Carr S, Rehm J, Manthey J (2021) Guidelines and reality in studies on the economic costs of alcohol use: a systematic review. The International Journal of Alcohol and Drug Research. https://doi.org/10.7895/ijadr.283
  • Lehmann K, Kuhn S, Baschirotto C, Jacobsen B, Walcher S, Görne H, Backmund M, Scherbaum N, Reimer J, Verthein U (2021) Substitution treatment for opioid dependence with slow-release oral morphine: Retention rate, health status, and substance use after switching to morphine. J Sub Abuse Treat;  doi.org/10.1016/j.jsat.2021.108350
  • Buchholz A, Spies M, Härter M, Lindemann C, Schulte B, Kiefer F, Frischknecht U, Reimer J, Verthein U (2021) Barrieren und Umsetzungsstrategien für die Implementierung der S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener Störungen aus Sicht von Behandlern und Betroffenen. Suchttherapie; eFirst DOI: 10.1055/a-1324-5217
  • Lehmann K, Kuhn S, Schulte B, Meyer-Thompson HG, Verthein U (2021) Die Substitutionstherapie Opioidabhängiger in Deutschland: Auswirkungen der 3. BtMVVÄndV aus der Sicht substituierender Ärztinnen und Ärzte. Gesundheitswesen, eFirst, DOI: 10.1055/a-1378-9249
  • Lehmann K, Kuhn S, Schulte B, Verthein U (2021) Relevanz und Auswirkungen der 3. BtMVVÄndV für die Opioidsubstitutionstherapie. Suchttherapie eFirst. DOI 10.1055/a-1330-6349
  • Kalke J, Schmidt CS, Hayer T (2021) Sportwetten: Expertise oder Glück? Ein systematischer Review über Tippstudien. Suchttherapie; 22: 27-36
  • Hayer T, Kalke J (2021) Sportwetten: Spielanreize und Risikopotenziale. Suchttherapie. Suchttherapie; 22: 11-18
  • Kokole D, Mercken L, Jané-Llopis E, Natera Rey G, Arroyo M, Medina P, Pérez-Gómez A, Mejía-Trujillo J, Piazza M, Bustamante IV, O'Donnell A, Kaner E, Gual A, Lopez-Pelayo H, Schulte B, Manthey J, Rehm J, Anderson P, de Vries H (2021) Perceived appropriateness of alcohol screening and brief advice programmes in Colombia, Mexico and Peru and barriers to their implementation in primary health care - a cross-sectional survey. Prim Health Care Res Dev, 28;22:e4. doi: 10.1017/S1463423620000675
  • Anderson P, Manthey J, Llopis EJ, Rey GN, Bustamante IV, Piazza M, Aguilar PSM, Mejía-Trujillo J, Pérez-Gómez A, Rowlands G, Lopez-Pelayo H, Mercken L, Kokole D, O'Donnell A, Solovei A, Kaner E, Schulte B, de Vries H, Schmidt C, Gual A, Rehm J. (2021) Impact of Training and Municipal Support on Primary Health Care-Based Measurement of Alcohol Consumption in Three Latin American Countries: 5-Month Outcome Results of the Quasi-experimental Randomized SCALA Trial. J Gen Intern. doi: 10.1007/s11606-020-06503-9
  • Kilian C, Manthey J, Kraus L, Mäkelä P, Moskalewicz J, Sieroslawski J, Rehm J (2021) A new perspective on European drinking cultures: a model-based approach to determine variations in drinking practices among 19 European countries. Addiction. doi: 10.1111/add.15408
  • Raj N, Verthein U, Grundmann J, Lotzin A, Hiller P, Schulte B, Driessen M, Hillemacher T, Scherbaum N, Schäfer M, Schneider B, Schäfer I (2021) Internalizing and externalizing subtypes in female patients with co-occurring post-traumatic stress disorder and substance use disorders. J Subst Abuse Treat;121:108198. doi: 10.1016/j.jsat.2020.108198. 
  • Zimmermann R, Külper-Schiek W, Steffen G, Gillesberg Lassen S, Bremer V, Dudareva S; die Hepatitis-Monitoring-Arbeitsgruppe. Wie lässt sich die Eliminierung von Hepatitis B, C und D in Deutschland messen? Ergebnisse eines interdisziplinären Arbeitstreffens. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021 Jan;64(1):77-90